Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019 – 2025
- DPI Research
- April 2019
- 210 pages
The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.
“Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019 – 2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.
Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.
Further, prudent analysis has been done on the competitor’s part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech and VaxInnate are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.
The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.
The major and emerging companies dominating this market for its vaccines, services and continuous product developments are:
- Sanofi Pasteur
- GlaxoSmithKline (GSK)
- Seqirus (CSL Limited)
- Sinovac Biotech Ltd.
- Gamma Vaccines Pty Ltd.
- Hualan Biological Engineering Inc.
- Shanghai Institute of Biological Products Co., Ltd.
- Mitsubishi Tanabe Pharma
- BiondVax Pharmaceuticals Ltd
Twenty-One Major Markets(21MM) covered in the report are as follows:
- United States
- United Kingdom
- New Zealand
The Latest Industry Data Included in this Report:
- Global Influenza Vaccines Market Size and Analysis (2013 – 2025)
- Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
- Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025)
- Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 – 2025)
- Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 – 2025)
- Rapid Diagnostic Testing for the Management of Influenza
- Global Distribution Channel and Technique of Influenza Vaccination
- Promising Influenza Vaccines in Clinical Development
- Major Deals in the Global Influenza Vaccines Market
- Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
- Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
- A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development
Have query on this report?Make an Enquiry
Table of Contents
1. Executive Summary
2. Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
3. Global Influenza Vaccines Market Size and Analysis (2013 – 2025)
4. Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025)
4.1 Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast
4.2 Global Influenza Vaccines Market Share and Forecast
5. Key Drivers and Inhibitors of the Global Influenza Vaccines Market
5.1 Market Drivers
5.2 Market Inhibitors
List of Tables:
Table 4–1: Global Number of Persons Vaccinated with Influenza Vaccines Share (Percent),2013 – 2018
Table 4–2: Global Number of Persons Vaccinated with Influenza Vaccines Share Forecast (Percent),2019 – 2025
Table 4–3: Global Influenza Vaccines Market Share (Percent),2013 – 2018
Table 4–4: Global Influenza Vaccines Market Share Forecast (Percent),2019 – 2025
Table 7–1: Influenza Virus Testing Methods
Table 8–1: Distribution of Influenza Vaccination
Table 9–1: Merger & Acquisitions in Influenza Vaccines Market (Million US$),2003 – 2017
Table 9–2: Collaboration Deal in Influenza Vaccines Market,2007 – 2018
Table 9–3: Licensing Agreement in Influenza Vaccines Market,2007 – 2018
Table 9–4: Exclusive Agreement in Influenza Vaccines Market,2009 – 2016
Table 9–5: Distribution Agreement in Influenza Vaccines Market,2005 – 2016
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Vaccines
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017